abstract |
The present invention relates to the use of a compound of the formula Lys-X, wherein X is a hydroxyl group, an amino group, alkoxy, Pro or Pro-Thr, or a pharmaceutically acceptable salt thereof, for the treatment of Autoimmune diseases, allergic reactions and transplant rejection. |